Advertisements

Камастил

Quick links to important sections

Камастил

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Камастил

Quick Facts

Property Description
Active ingredient Sildenafil (Sildenafil Citrate)
Form Film-coated tablet
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
Common use Circulatory enhancement
Origin Synthetic compound

Камастил: Definition and Pharmacological Classification

Камастил is a pharmaceutical preparation that contains the single active substance Sildenafil, a synthetic compound classified as a Phosphodiesterase type 5 (PDE5) inhibitor. Sildenafil is the drug's International Nonproprietary Name (INN), a compound widely responsible for its therapeutic action, and is typically formulated as its citrate salt. This classification as a PDE5 inhibitor is clinically recognized across numerous authoritative medical bodies, defining the drug's core mechanism: the targeted blocking of a specific enzyme found in various body tissues. This pharmacological profile is supported by extensive research that consistently confirms Sildenafil’s selective action.

Composition and Pharmaceutical Form

The proprietary formulation is presented as a solid oral dosage form, specifically a film-coated tablet for oral administration. The tablet contains Sildenafil as the sole active ingredient. As a manufactured preparation, Камастил’s specific formulation includes various inactive components, known as solid oral dosage form excipients, which are necessary to establish the product’s integrity, stability, and consistent profile, differentiating it from generic chemical powder.

General Therapeutic Role

The general therapeutic purpose of this medication is to act as a targeted circulation enhancer via the mechanism of vasodilation. The PDE5 inhibitor Sildenafil promotes the relaxation of vascular smooth muscle by selectively preventing the rapid degradation of a molecule known as cyclic Guanosine Monophosphate (cGMP). This core physiological effect defines Камастил's clinical utility as an Erectile Dysfunction Agent and provides the basis for its use in treating Pulmonary Arterial Hypertension—applications supported by official regulatory approvals.

Advertisements

What side effects are possible with Камастил?

Adverse Reactions and Safety Information

Common Side Effects

The most commonly reported adverse reactions (ge 2% incidence) are generally mild and transient, primarily reflecting the drug’s vasodilatory properties. These include headache, flushing (redness or warmth of the face/neck), dyspepsia (upset stomach), abnormal vision (such as a blue-color tinge or blurred vision), and nasal congestion.

Serious and Clinically Significant Risks

Regulatory warnings highlight rare but serious side effects that require immediate medical attention to prevent potential permanent damage. These include:

  • Priapism: A prolonged erection lasting more than four hours.
  • Sudden Vision Loss: This may be a sign of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), a serious eye condition.
  • Sudden Hearing Decrease or Loss: This may be accompanied by tinnitus (ringing in the ears) or dizziness.

Serious cardiovascular events (e.g., myocardial infarction, stroke) have been reported post-marketing, often in individuals with pre-existing risk factors.

Contraindications and Safety Restrictions

Камастил is contraindicated (should not be used) if taking nitrates (in any form for chest pain) or guanylate cyclase stimulators (like riociguat), due to the risk of a severe, life-threatening drop in blood pressure. The drug is also contraindicated for individuals with known hypersensitivity to the medication.

Caution is advised for patients with certain pre-existing conditions, including cardiovascular disease (where sexual activity is inadvisable), a history of NAION, anatomical deformation of the penis, or blood disorders that predispose to priapism (e.g., sickle cell anemia, multiple myeloma).

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Камастил (Sildenafil Citrate) overdose focuses on time-critical, severe manifestations resulting from high drug exposure. Overdose may present with exaggerated symptoms of Sildenafil’s known effects, including decreased blood pressure (hypotension), syncope (fainting), and a prolonged erection. Regulatory documentation classifies the risk by emphasizing life-threatening outcomes, such as serious cardiovascular events (e.g., myocardial infarction, ventricular arrhythmia) and severe sensory deficits.


When Immediate Medical Help is Required

Immediate medical assistance is mandated for any erection persisting longer than four hours (priapism), as this is a time-critical emergency that risks permanent tissue damage. Patients must also stop taking Sildenafil and consult a physician immediately for sudden visual defect or loss of vision, and promptly for sudden decrease or loss of hearing.


Overdose Management

Due to the drug’s high plasma protein binding and the fact that no specific antidote is known, the authorized overdose management is strictly symptomatic and supportive. Treatment involves general supportive measures, including specific protocols for managing hypotension (e.g., supine positioning and intravenous fluids). Individuals with severe renal or hepatic impairment may be at a higher risk of adverse effects due to reduced drug clearance.

Advertisements

Therapeutic Uses of Камастил

Камастил: Main Uses and Key Therapeutic Benefits

Easing Symptomatic Discomfort and Acute Episodes

The medication is commonly used to help with acute or disruptive episodes where a patient experiences symptoms related to physical discomfort or systemic imbalance. In such cases, supportive symptom management is often appropriate. Камастил is applied in addressing symptom clusters that may become intense or appear suddenly, helpful in situations requiring additional symptomatic assistance. It **is applied in contexts where additional support for symptom management is needed.

Supporting Daily Stability and Functional Comfort

Камастил is relevant for easing symptoms that interfere with daily functioning and create noticeable physiological strain. It offers symptomatic relief that helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases. It may assist with maintaining functional stability when symptoms become more noticeable. Contributes to easing the overall symptom load during symptomatic periods.

Assisting with Episodes of Increased Tension

The medicine is considered relevant and is commonly used across conditions presenting with acute episodes, as well as used in situations involving recurrent or episodic manifestations. It is applied during phases of increased distress or discomfort when short-term symptomatic assistance is needed, and is relevant in contexts marked by increased discomfort or tension. It **is applied across domains where additional symptomatic support is needed.

Quick Fact: Relevant for Temporary Functional Strain

Regulatory References

  1. NIH guidance on pain management
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Камастил? — Official Regulatory Information

The eligibility profile for Камастил (Sildenafil) is defined by official government regulatory documents, focusing on absolute exclusions and populations requiring special consideration.

Category Regulatory Status
Populations for whom use is allowed Adult males (18 years and older) for the indicated use.
Populations for whom use is contraindicated Patients using nitrate medications (in any form) or guanylate cyclase (GC) stimulators (e.g., riociguat); Patients with known hypersensitivity to Sildenafil; Individuals for whom sexual activity is inadvisable due to severe cardiovascular conditions; Patients with a history of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).

Age-Related Eligibility Rules

The medication is not indicated for individuals under 18 years of age for the treatment of erectile dysfunction. Use in older adults (65 years and older) is permitted, but a reduced starting dose may be required due to changes in drug clearance.

Condition-Specific Eligibility Rules

Patients with severe renal impairment (creatinine clearance < 30 mL/min) or hepatic impairment (e.g., cirrhosis) should consider a lower initial dose as advised in the label. The medicine is generally not indicated for women, which includes during pregnancy and lactation, as safety and efficacy data are not established for this population.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Камастил (Atorvastatin) interactions are primarily governed by its metabolism and transport, requiring careful management with co-administered substances. The official regulatory profile identifies several key interaction categories.

Key Interaction Categories

Interaction Type Practical Implication
Pharmacokinetic (CYP3A4/Transporter) Co-administration with potent CYP3A4 inhibitors (e.g., certain antifungals or protease inhibitors) significantly increases Atorvastatin plasma levels, raising the risk of myopathy.
Pharmacodynamic Combining with other muscle-toxic agents, such as fibrates (e.g., Gemfibrozil) or high-dose Niacin (1 g/day), enhances the risk of muscle toxicity.
Absorption Modifiers Concomitant use with Colestipol reduces Atorvastatin concentrations; dosing must be separated by several hours to maintain efficacy.
Effects on Co-administered Drugs Atorvastatin can increase the plasma concentrations of certain drugs, including Digoxin and the components of Oral Contraceptives (Ethinyl Estradiol and Norethindrone).
Dietary Consumption of large quantities of Grapefruit Juice (1.2 liters/day) is officially restricted due to its ability to inhibit intestinal metabolism and increase drug exposure.

Regulatory Restrictions

Official labeling mandates that certain highly interacting drugs, such as specific potent CYP3A4 inhibitors or Cyclosporine, are to be avoided or used with strict dose limitations. This framework manages the risk of adverse events by controlling the systemic exposure of Atorvastatin, ensuring that plasma concentrations remain within safe and effective limits as defined by regulatory standards.

Advertisements

Mechanism of Action

The mechanism of Sildenafil involves the selective modulation of a key enzyme-mediated signaling pathway in the body. Its action is strictly dependent on the body's natural processes and does not initiate the signaling chain itself.

The medication acts within the domain of enzyme-mediated signaling by selectively inhibiting the Phosphodiesterase type 5 (PDE5) enzyme, which is the primary molecular target. This inhibition prevents the rapid degradation of the secondary messenger molecule cyclic Guanosine Monophosphate (cGMP), resulting in a more sustained signaling response within the affected cells.

The key pathway affected is the Nitric Oxide (NO)-cGMP signal transduction cascade, a system that naturally regulates the relaxation of smooth muscle in blood vessels. By preserving cGMP, the drug potentiates this natural signal, translating the initial molecular action into a reduction of localized vascular tone.

The consequence of the sustained cGMP signal is the relaxation of vascular smooth muscle in target areas of the circulation, which is a consequence of altered smooth muscle contractile patterns. This resulting localized vasodilation is the physiological adjustment that increases blood flow and perfusion pressure in the targeted vascular beds.

Advertisements

Dosage and Administration Information

How to Use Камастил: Official Administration Guidelines

Камастил (Sildenafil) is administered according to distinct protocols, with the route, dose, and frequency determined strictly by the condition being addressed: Erectile Dysfunction (ED) or Pulmonary Arterial Hypertension (PAH). All usage patterns are derived from established prescribing information.


Administration Scope

Instruction Category Details
Route of administration Primarily Oral (tablet/suspension). Intravenous (IV) bolus injection is an approved route for PAH patients temporarily unable to take the oral form.
Frequency pattern As-needed (PRN) with a maximum of once per day for ED, or Three times a day (TID) for PAH.
Dosing schedule (ED) Starting oral dose is 50 mg, adjustable within a 25 mg to 100 mg range.
Dosing schedule (PAH) Standard oral dose is 20 mg TID, adjustable up to 80 mg TID. The IV dose is 10 mg TID.
Timing constraints For ED, it is taken with or without food approximately 30 minutes to 4 hours before activity. A high-fat meal may delay activity onset.
Population adjustments A lower starting dose of 25 mg should be considered for ED in older adults (>65 years) and patients with severe renal or hepatic impairment.

Resulting Procedural Structure

The official instruction sets establish a clear procedural split: ED treatment involves an acute, single administration event (up to 100 mg) within a 24-hour window, while PAH treatment involves a continuous, fixed-schedule administration (TID) that often requires long-term adherence. Specific constraints apply, such as limiting the maximum dose to 25 mg within 48 hours when co-administered with Ritonavir, standardizing the use protocol.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Non-Steroidal Compound (NSC)

Research has documented a broad range of studies investigating the effects of the Non-Steroidal Compound (NSC). The focus of this research generally falls under studies reporting on pain and fever measurements.

Pain and Fever Management

Studies collected data on clinical symptoms in adult populations with acute, self-limiting conditions. The primary research tracked the duration and severity of the common cold in relation to the combination. Studies evaluated data regarding fever. The studies reported on changes in pain levels during the treatment period.

Sympathomimetic Agent (SA)

Research primarily explores findings related to the Sympathomimetic Agent (SA) and upper respiratory tract symptoms. This component has been extensively investigated for its role in addressing nasal congestion.

Role in Nasal Congestion

Research has explored observations related to nasal congestion. The component has been investigated for its systemic effects. Studies included monitoring of inflammation and recovery time in participants receiving the component.

Combination Therapy Studies

A significant body of research exists comparing the effects of the two components used together versus separate use.

Combined vs. Monotherapy Evaluation

Studies compared the combination to monotherapy and recorded and analyzed how they compare in various outcomes. Research has documented patterns of use during which various clinical observations were reported. Studies collected and examined data concerning co-occurring cardiovascular issues. Data has been collected in adult populations regarding the component's effects.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Камастил (FAQ)

Q: Are the common side effects of Камастил typically temporary or long-lasting?

Official product information indicates that the most commonly reported side effects are generally transient, meaning they are temporary. These reactions are typically classified as mild to moderate in severity and are generally expected to resolve.

Q: Is it normal to feel mild fatigue or tiredness when first using Камастил?

Based on official safety data, mild fatigue or tiredness is not listed as a commonly reported adverse reaction (i.e., one occurring frequently in clinical trials). However, official information does list insomnia (difficulty sleeping) as a common side effect and dizziness as a potential side effect.

Q: Does taking Камастил cause long-term changes to the body?

Official warnings highlight that rare but serious reactions may lead to permanent damage. Specifically, potential permanent loss of vision from NAION (Non-arteritic Anterior Ischemic Optic Neuropathy) and permanent damage resulting from untreated priapism (a prolonged erection) have been documented.

Q: Can Камастил lead to changes in appetite or weight?

Changes to appetite are not listed as a common side effect in official documents. However, uncommon reports collected during post-marketing surveillance mention metabolic effects, including increased weight and fluid retention.

Q: Does Камастил affect sleep patterns?

Yes, official adverse reaction data indicates that insomnia (trouble sleeping) is a commonly reported side effect associated with the use of the medication.

Q: Is there a known interaction between Камастил and alcohol?

Sildenafil, the active ingredient, is known to promote vasodilation, which can lower blood pressure. Combining it with alcohol, which also has vasodilating effects, may increase the chance of experiencing related symptoms such as dizziness or headache.

Q: Should specific vitamins or herbal supplements be avoided while using Камастил?

The regulatory label specifically restricts consuming large amounts of Grapefruit Juice due to its effect on drug metabolism. While no specific vitamins or common herbs are restricted, patients are generally advised in the official patient counseling information to inform their healthcare provider about all supplements they are taking.

Q: Are there any common foods or beverages that interact with Камастил?

Yes, official regulatory information specifies that large amounts of Grapefruit Juice should be avoided. Additionally, for the treatment of Erectile Dysfunction, taking the medication with a high-fat meal may delay the time it takes for the drug to begin working.

Q: What non-prescription drugs are documented to interact with Камастил?

Regulatory information primarily addresses interactions with prescription medicines. The only commonly consumed substance mentioned that is known to affect the drug's metabolism is Grapefruit Juice.

Q: If Камастил is stopped, how long does it take for the drug to leave the body?

According to the pharmacokinetics data in the official documents, the drug is cleared from the body through metabolism. The average terminal half-life of Sildenafil (the active ingredient) and its major active metabolite is approximately 4 hours.

Q: Does having a chronic condition like diabetes affect eligibility for Камастил?

Based on the official label, diabetes mellitus is not listed as a contraindication or a condition automatically requiring a dose adjustment. However, clinical studies have noted a potentially lower response rate in patients with diabetes when the medication is used for Erectile Dysfunction.

Q: Can Камастил affect the ability to drive or operate machinery?

Since Камастил can cause side effects such as dizziness and visual disturbances (including blurred vision or color tinge), patients should be aware that these effects may potentially impair the ability to drive or operate machinery.

Q: What is known about the long-term effects of Камастил usage?

Clinical trials have documented that the efficacy of Sildenafil is maintained in Erectile Dysfunction patients over periods of one year or longer. The long-term safety of the medication continues to be evaluated through ongoing post-marketing surveillance programs.

Q: Are there ongoing clinical trials for Камастил?

Independent research related to Sildenafil’s potential uses is documented in official research registries. These areas include investigations into pulmonary hypertension and certain types of infertility.

Q: What is the current regulatory safety status of Камастил in major markets?

The official regulatory safety profile is defined by specific contraindications (such as use with nitrate medications) and detailed warnings regarding serious risks (including NAION and priapism). These restrictions and warnings mandate extensive patient counseling, ensuring proper use.

Q: Can I split or crush Камастил if I have trouble swallowing?

The medication is manufactured as a film-coated tablet, and the official labeling does not include instructions or allowances for splitting or crushing it. If a patient is unable to swallow the tablet, an approved oral suspension formulation is available for the Pulmonary Arterial Hypertension indication.

Q: What is the risk of dependency or withdrawal associated with Камастил?

Sildenafil is not classified as habit-forming in regulatory documentation. Therefore, it is not associated with a risk of physical dependency or the development of physical withdrawal symptoms upon discontinuation.

Q: Does Камастил lose its effectiveness over time? (Tolerance)

Official clinical trial data on long-term use in patients with Erectile Dysfunction has shown that the medication's efficacy is maintained over periods of one year or longer. The long-term clinical trial data has shown that the medication's efficacy is maintained over periods of one year or longer.

Q: Does Камастил affect results of common blood tests?

Studies have investigated the drug’s potential impact on blood coagulation. Official documents indicate that Sildenafil has no clinically relevant effect on bleeding time when taken alone or when co-administered with aspirin.

Q: Is it possible to develop an allergy to Камастил even after using it for a while?

While the drug is contraindicated for anyone with a known hypersensitivity (allergy) to it, post-marketing safety reports have documented rare cases of severe hypersensitivity reactions, including anaphylactic shock. Post-marketing reports suggest that a reaction may potentially occur even after the initial use period.

Q: What determines the typical half-life of Камастил?

The half-life, which defines how quickly the substance is cleared from the body, is determined by the body's metabolism process. The primary route of clearance is through the liver's cytochrome P450 enzymes, mainly CYP3A4 and to a lesser extent, CYP2C9.

Advertisements

How should Камастил be stored and disposed of?

Storage Requirements

Official regulatory documents require that Камастил (Sildenafil tablets) be stored at Controlled Room Temperature, typically maintained between 20 C and 25 C (68 F and 77 F). The product must be protected from both heat and freezing temperatures, and it should be shielded from light and moisture to preserve stability until the expiration date. It is mandated that the medication be kept in the container it was dispensed in, with the container tightly closed.

Child Safety and Disposal

For safety, the tablets must be kept out of the sight and reach of children at all times. Disposal of unused or expired medicine should follow official protocols. The preferred method is using a designated drug take-back program. If a take-back program is unavailable, the unused tablets should be mixed with an undesirable substance, sealed in a bag, and then discarded in the household trash, rather than being flushed down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Камастил found in:

A-Z Index: